Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

PAR Technology Receives Buy Rating Upgrade with 61 Price Target

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, PAR Technology (NYSE: PAR) received a significant upgrade from analyst Ishfaque Faruk at Sidoti & Co. The rating was raised from Neutral to Buy, with a new price target of $61. This adjustment indicates a bullish perspective on the company’s trajectory and expansion opportunities.

According to analysts surveyed by Capital IQ, PAR Technology has garnered an average outperform rating, with price targets ranging from $40 to $65. This upgrade marks a notable shift in sentiment towards a more favorable outlook on the company’s potential for growth and success in the market.

PAR Stock Shows Impressive Performance on March 12, 2024 with Strong Momentum and Growth Potential

On March 12, 2024, PAR stock showed strong performance as it traded near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, the price of PAR shares increased by $2.93 since the market last closed, representing a significant 6.98% rise. The stock opened at $43.95, which was $1.89 higher than its previous close, indicating positive investor sentiment and potential for further growth throughout the trading day. PAR’s price momentum on this day was impressive, with the stock showing resilience and potential for continued upward movement. Trading near the top of its 52-week range suggests that investors have confidence in the company’s performance and outlook. Overall, PAR’s stock performance on March 12, 2024, was impressive, with the stock showing strong momentum and potential for continued growth. Investors who were able to capitalize on this opportunity would have seen significant returns on their investment.

PAR Stock Performance Analysis: Revenue Up, Net Income Mixed, EPS Shows Modest Increase

On March 12, 2024, PAR stock had a mixed performance based on the financial data provided by CNN Money. The total revenue for the company was reported at $415.82 million for the past year, showing an increase of 16.87% compared to the previous year. However, the total revenue remained flat at $107.71 million for the last quarter.

Similarly, the net income for PAR was -$69.75 million for the past year, with a slight increase of 0.62% compared to the previous year. The net income for the last quarter was reported at -$18.63 million, showing no change from the previous quarter.

Furthermore, the earnings per share (EPS) for PAR stock was reported at -$2.53 for the past year, with a modest increase of 0.84% compared to the previous year. The EPS for the last quarter was -$0.67, showing no change from the previous quarter.

Overall, the financial performance of PAR stock on March 12, 2024, was a mixed bag. While the total revenue and net income showed some improvement compared to the previous year, the numbers remained flat for the last quarter. The EPS also saw a slight increase compared to the previous year, but remained unchanged for the last quarter.

Investors may want to closely monitor the performance of PAR stock in the coming quarters to see if the company can sustain its revenue growth and improve its net income. It will be interesting to see if the company can continue to drive its earnings per share higher in the future.

Tags: PAR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Healthcare Services Stock Exchange

Analyst Emily Bodnar Reaffirms NovoCure with Neutral Rating and 22 Price Target

Finance_ Trading ratings today (2)

Goldman Sachs Analyst Recommends Selling CalMaine Foods with Increased Price Target

Energy Company Market Capitalization

Analyst Ratings and Price Targets for Petrobras Brasileiro A Dynamic Market Landscape

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com